Mobility Global MBGL 深 滬
等待開盤 09-08 09:30:00 美东时间
20.58
+0.120
+0.59%
華盛通- 最 高20.615
- 今 開20.33
- 成交量 336.92万股
- 最 低 20.2101
- 昨 收 20.46
- 總市值 658.56万
- 52周最高 25.94
- 市盈率 靜 27.60
- 換手率 1052.86%
- 52周最低 17.61
- 委 比 84.91%
- 總股本 0.00亿
- 歷史最高 25.94
- 量 比 0.92
- 振 幅 1.98%
- 歷史最低 17.61
- 每 手 1
- 風險率 2.98%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
Barclays Initiates Coverage On Mobility Global with Equal-Weight Rating, Announces Price Target of $23
Barclays analyst Manav Patnaik initiates coverage on Mobility Global (NYSE:MBGL) with a Equal-Weight rating and announces Price Target of $23.
09-02 02:42
CARFAX: These States Are Furthest Behind on Car Maintenance
Millions of Drivers Behind on Recommended Maintenance as Back-to-School Driving Begins CENTREVILLE, Va., Aug. 25, 2026 /PRNewswire/ -- As millions of families head back to school and return ...
08-25 20:00
CARFAX: Which Vehicles are the Most Reliable?
CARFAX Names Top 3 Reliability Rankings for Cars, SUVs, and Trucks CENTREVILLE, Va., Aug. 17, 2026 /PRNewswire/ -- CARFAX has compiled a ranking of the most reliable vehicle types based on b...
08-17 20:00
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Citigroup Initiates Coverage On Mobility Global with Neutral Rating, Announces Price Target of $23
Citigroup analyst Peter Christiansen initiates coverage on Mobility Global (NYSE:MBGL) with a Neutral rating and announces Price Target of $23.
08-12 03:13
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
Mobility Global Sees FY2026 Sales $1.870B-$1.885B vs $1.897B Est
Mobility Global (NYSE:MBGL) sees FY2026 sales of $1.870 billion-$1.885 billion vs $1.897 billion analyst estimate.
08-07 21:03
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
Wells Fargo Maintains Overweight on Mobility Global, Lowers Price Target to $25
Wells Fargo analyst Jason Haas maintains Mobility Global (NYSE:MBGL) with a Overweight and lowers the price target from $27 to $25.
08-04 21:24
